REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrum Biotechnologii Sp. z o.o. (Poland)

Main Activities: Lessors of Real Estate
Full name: Centrum Biotechnologii Sp. z o.o. Profile Updated: February 15, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Centrum Biotechnologii Sp. z o.o. is based in Poland, with the head office in Zlotniki. The enterprise operates in the Lessors of Real Estate industry. The company was established on July 24, 2007. Centrum Biotechnologii Sp. z o.o. currently employs 21 - 50 (2013) people. The latest financial highlights indicate a net sales revenue increase of 50.33% in 2021. Its’ total assets recorded a negative growth of 12.99%. The net profit margin of Centrum Biotechnologii Sp. z o.o. decreased by 100.4% in 2021.

Headquarters
Ul. Krzemowa 1
Zlotniki; Wielkopolskie; Postal Code: 62-002

Contact Details: Purchase the Centrum Biotechnologii Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Centrum Biotechnologii Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Centrum Biotechnologii Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Centrum Biotechnologii Sp. z o.o. report to view the information.
Incorporation Date:
July 24, 2007
Subsidiaries
Nu Delta Sp. z o.o.
35%
Plast Compound Processing Sp. z o.o.
31.82%
Cem-Kolor Sp. z o.o.
30.06%
Company Performance
Financial values in the chart are available after Centrum Biotechnologii Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
50.33%
Total operating revenue
47.28%
Operating profit (EBIT)
20.09%
EBITDA
15.56%
Net Profit (Loss) for the Period
-72.79%
Total Assets
-12.99%
Total Equity
8.05%
Operating Profit Margin (ROS)
-11.4%
Net Profit Margin
-100.4%
Return on Equity (ROE)
-22.13%
Debt/Equity
-15.65%
Quick Ratio
0.87%
Cash Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?